Literature DB >> 27091600

Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.

Kymberly D Young1, Wayne C Drevets2, Robert Dantzer3, T Kent Teague4, Jerzy Bodurka5, Jonathan Savitz6.   

Abstract

Inflammation-related changes in the concentrations of inflammatory mediators such as c-reactive protein (CRP), interleukin 1β (IL-1), and IL-6 as well as kynurenine metabolites are associated with major depressive disorder (MDD) and affect depressive behavior, cognition, and hippocampal plasticity in animal models. We previously reported that the ratios of kynurenic acid (KynA) to the neurotoxic metabolites, 3-hydroxykynurenine (3HK) and quinolinic acid (QA), were positively correlated with hippocampal volume in depression. The hippocampus is critical for autobiographical memory (AM) recall which is impaired in MDD. Here we tested whether the ratios, KynA/3HK and KynA/QA were associated with AM recall performance as well as hippocampal activity during AM recall. Thirty-five unmedicated depressed participants and 25 healthy controls (HCs) underwent fMRI scanning while recalling emotionally-valenced AMs and provided serum samples for the quantification of kynurenine metabolites, CRP, and cytokines (IL-1 receptor antagonist - IL-1RA; IL-6, tumor necrosis factor alpha - TNF, interferon gamma -IFN-γ, IL-10). KynA/3HK and KynA/QA were lower in the MDD group relative to the HCs. The concentrations of the CRP and the cytokines did not differ significantly between the HCs and the MDD group. Depressed individuals recalled fewer specific AMs and displayed increased left hippocampal activity during the recall of positive and negative memories. KynA/3HK was inversely associated with left hippocampal activity during specific AM recall in the MDD group. Further, KynA/QA was positively correlated with percent negative specific memories recalled in the MDD group and showed a non-significant trend toward a positive correlation with percent positive specific memories recalled in HCs. In contrast, neither CRP nor the cytokines were significantly associated with AM recall or activity of the hippocampus during AM recall. Conceivably, an imbalance in levels of KynA versus QA-pathway metabolites may adversely impact the function of the hippocampus and AM recall, raising the possibility that kynurenine pathway may affect emotion-dependent memory within the context of depression.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippocampus; Magnetic resonance imaging; Major depressive disorder; Memory; Quinolinic acid

Mesh:

Substances:

Year:  2016        PMID: 27091600      PMCID: PMC4917447          DOI: 10.1016/j.bbi.2016.04.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  54 in total

1.  Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Authors:  Katherine J Bangen; Khaled Restom; Thomas T Liu; Christina E Wierenga; Amy J Jak; David P Salmon; Mark W Bondi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

3.  Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.

Authors:  Daniel Zwilling; Shao-Yi Huang; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Paolo Guidetti; Hui-Qiu Wu; Jason Lee; Jennifer Truong; Yaisa Andrews-Zwilling; Eric W Hsieh; Jamie Y Louie; Tiffany Wu; Kimberly Scearce-Levie; Christina Patrick; Anthony Adame; Flaviano Giorgini; Saliha Moussaoui; Grit Laue; Arash Rassoulpour; Gunnar Flik; Yadong Huang; Joseph M Muchowski; Eliezer Masliah; Robert Schwarcz; Paul J Muchowski
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

4.  Cerebrospinal cytokine levels in patients with acute depression.

Authors:  J Levine; Y Barak; K N Chengappa; A Rapoport; M Rebey; V Barak
Journal:  Neuropsychobiology       Date:  1999-11       Impact factor: 2.328

5.  Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Xinguo Ren; Jawed Fareed; Debra A Hoppensteadt; Rosalinda C Roberts; Robert R Conley; Yogesh Dwivedi
Journal:  J Psychiatr Res       Date:  2011-09-08       Impact factor: 4.791

Review 6.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

7.  Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Authors:  Daniel Lindqvist; Shorena Janelidze; Peter Hagell; Sophie Erhardt; Martin Samuelsson; Lennart Minthon; Oskar Hansson; Maria Björkqvist; Lil Träskman-Bendz; Lena Brundin
Journal:  Biol Psychiatry       Date:  2009-03-06       Impact factor: 13.382

Review 8.  An expanding range of targets for kynurenine metabolites of tryptophan.

Authors:  Trevor W Stone; Nicholas Stoy; L Gail Darlington
Journal:  Trends Pharmacol Sci       Date:  2012-11-01       Impact factor: 14.819

9.  Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.

Authors:  Caroline André; Jason C O'Connor; Keith W Kelley; Jacques Lestage; Robert Dantzer; Nathalie Castanon
Journal:  J Neuroimmunol       Date:  2008-07-23       Impact factor: 3.478

10.  Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.

Authors:  Adam S Fleisher; Katherine M Podraza; Katherine J Bangen; Curtis Taylor; Ayesha Sherzai; Kunal Sidhar; Thomas T Liu; Anders M Dale; Richard B Buxton
Journal:  Neurobiol Aging       Date:  2008-03-05       Impact factor: 4.673

View more
  21 in total

Review 1.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

2.  A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls.

Authors:  Samuel J DeWitt; Kailyn A Bradley; Na Lin; Chunli Yu; Vilma Gabbay
Journal:  J Affect Disord       Date:  2017-11-20       Impact factor: 4.839

Review 3.  Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

Authors:  Benjamin Heng; Gilles J Guillemin; Bahar Kavyani; Brett A Lidbury; Richard Schloeffel; Paul R Fisher; Daniel Missailidis; Sarah J Annesley; Mona Dehhaghi
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

4.  Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.

Authors:  Timothy B Meier; Wayne C Drevets; T Kent Teague; Brent E Wurfel; Sven C Mueller; Jerzy Bodurka; Robert Dantzer; Jonathan Savitz
Journal:  Brain Behav Immun       Date:  2017-09-01       Impact factor: 7.217

5.  Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.

Authors:  Flurin Cathomas; Karoline Guetter; Federica Klaus; Stefan Kaiser; Erich Seifritz
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

6.  Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathway.

Authors:  Auriel A Willette; Colleen Pappas; Nathan Hoth; Qian Wang; Brandon Klinedinst; Sara A Willette; Brittany Larsen; Amy Pollpeter; Tianqi Li; Scott Le; Ana D Collazo-Martinez; Jonathan P Mochel; Karin Allenspach; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2021-03-26       Impact factor: 19.227

7.  Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.

Authors:  Jonathan Savitz; Bart N Ford; Hung-Wen Yeh; Elisabeth Akeman; Kelly Cosgrove; Ashley N Clausen; Christopher Martell; Namik Kirlic; Jessica Santiago; T Kent Teague; Michael R Irwin; Martin P Paulus; Robin L Aupperle
Journal:  Psychol Med       Date:  2020-11-25       Impact factor: 10.592

8.  Serum kynurenic acid is reduced in affective psychosis.

Authors:  B E Wurfel; W C Drevets; S A Bliss; J R McMillin; H Suzuki; B N Ford; H M Morris; T K Teague; R Dantzer; J B Savitz
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

9.  Immunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.

Authors:  Alexandra K Brooks; Marcus A Lawson; Jennifer L Rytych; Kevin C Yu; Tiffany M Janda; Andrew J Steelman; Robert H McCusker
Journal:  Front Immunol       Date:  2016-10-17       Impact factor: 7.561

Review 10.  The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes.

Authors:  Timothy B Meier; Jonathan Savitz
Journal:  Biol Psychiatry       Date:  2021-05-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.